Health Condition 1: C801- Malignant (primary) neoplasm, unspecified
Conditions
Interventions
Intervention1: Nil: Nil
Intervention2: Nil: Nil
Intervention3: Nil: Nil
Intervention4: Nil: Nil
Sponsors
Sree Sowmya Dantuluri
Eligibility
Inclusion criteria
Inclusion criteria: Diagnosed cancer patients Starting chemotherapy (oral or IV) Able to give informed consent
Exclusion criteria
Exclusion criteria: Severe cognitive/psychiatric impairment Patients unable to consent Non-chemotherapy treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mean number of Drug-Related Problems (DRPs) per patient during the first two chemotherapy cyclesTimepoint: Baseline, 3 Weeks and 6 Weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient knowledge score after counselingTimepoint: baseline & 3 weeks;Early toxicity burden (CTCAE v5.0 & PRO-CTCAE)Timepoint: 3 weeks & 6 weeks;Number of unplanned emergency room visits or unscheduled clinic visitsTimepoint: 4 weeks;Adherence to supportive care measures (antiemetics, oral care, etc.)Timepoint: 3 weeks & 6 weeks;Patient satisfaction levelTimepoint: 3 weeks;Counseling time durationTimepoint: At baseline | — |
Countries
India
Contacts
Public ContactDr Prashant B Patel
Department of Pharmacy, Sumandeep Vidyapeeth Deemed to be University
Outcome results
None listed